Aster Capital Management (Difc) LTD Ardelyx, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Ardelyx, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 677 shares of ARDX stock, worth $4,150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
677
Previous 1,842
63.25%
Holding current value
$4,150
Previous $12.7 Million
72.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
233Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Janus Henderson Group PLC London, X024.4MShares$149 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$88 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$71.1 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$63.4 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $948M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...